AKT1 and hepatocellular carcinoma: These data indicate that the suppression of SR HCC cell proliferation in compound 9a-treated cells arises primarily from blocking the AKT/p70S6 pathway and inducing caspase 3/PARP-dependent apoptotic signalling.